These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20830810)

  • 41. Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats.
    Kato N; Yashima S; Suzuki T; Nakayama Y; Jomori T
    J Diabetes Complications; 2003; 17(6):374-9. PubMed ID: 14583184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of nitrogen monoxide and its synthase on the diabetic retinal damage].
    Liu QH; Xie P; Ge YB; Yuan XR
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):837-41. PubMed ID: 16191353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina.
    Park JW; Park SJ; Park SH; Kim KY; Chung JW; Chun MH; Oh SJ
    Neurobiol Dis; 2006 Jan; 21(1):43-9. PubMed ID: 16023354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.
    Chen W; Yao X; Zhou C; Zhang Z; Gui G; Lin B
    Mediators Inflamm; 2017; 2017():3059763. PubMed ID: 28638179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: Effect on glucose transporter-1 and GAP43 expression.
    Mohammad HMF; Sami MM; Makary S; Toraih EA; Mohamed AO; El-Ghaiesh SH
    Life Sci; 2019 Sep; 232():116588. PubMed ID: 31226418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.
    Carr BC; Emigh CE; Bennett LD; Pansick AD; Birch DG; Nguyen C
    Retina; 2017 Jan; 37(1):22-31. PubMed ID: 27380429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.
    Talahalli R; Zarini S; Sheibani N; Murphy RC; Gubitosi-Klug RA
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1699-708. PubMed ID: 19834040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy.
    Giove TJ; Deshpande MM; Gagen CS; Eldred WD
    Mol Vis; 2009 Nov; 15():2249-58. PubMed ID: 19936028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
    Djordjevic B; Cvetkovic T; Stoimenov TJ; Despotovic M; Zivanovic S; Basic J; Veljkovic A; Velickov A; Kocic G; Pavlovic D; Sokolovic D
    Eur J Pharmacol; 2018 Aug; 833():290-297. PubMed ID: 29890158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
    Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
    Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats.
    Rosales MA; Silva KC; Lopes de Faria JB; Lopes de Faria JM
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4327-36. PubMed ID: 20335612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients.
    Kowluru RA; Kanwar M; Chan PS; Zhang JP
    Arch Ophthalmol; 2008 Sep; 126(9):1266-72. PubMed ID: 18779489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus.
    Abu El-Asrar AM; Desmet S; Meersschaert A; Dralands L; Missotten L; Geboes K
    Am J Ophthalmol; 2001 Oct; 132(4):551-6. PubMed ID: 11589878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
    Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
    Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats.
    Elgayar SA; Eltony SA; Sayed AA; Abdel-Rouf MM
    Ultrastruct Pathol; 2015; 39(6):385-94. PubMed ID: 26548435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of blood flow in diabetic retinopathy.
    Nippert AR; Newman EA
    Vis Neurosci; 2020 Jul; 37():E004. PubMed ID: 32684188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats.
    Kumar B; Gupta SK; Nag TC; Srivastava S; Saxena R; Jha KA; Srinivasan BP
    Exp Eye Res; 2014 Aug; 125():193-202. PubMed ID: 24952278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
    Sohn E; Kim J; Kim CS; Lee YM; Kim JS
    Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.